This announcement is a separate document:
以岭药业:北京国枫律师事务所关于石家庄以岭药业股份有限公司2023年第二次临时股东大会的法律意见书
Yiling Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the Second Extraordinary General Meeting of Shareholders of Shijiazhuang Yiling Pharmaceutical Co., Ltd. in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.